Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion type Assertion NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_head.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion wasGeneratedBy ECO_0000203 NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_provenance.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion wasDerivedFrom befree-2016 NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_provenance.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion SIO_000772 23596146 NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_provenance.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion evidence source_evidence_literature NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_provenance.
- NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_assertion description "[As almost all patients with high-risk neuroblastomas have autograft, we aimed to determine if minimal residual disease (MRD) quantified by RT-PCR for tyrosine hydroxylase in PBSC is prognostic in neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1070543.RAjdP0I4Pn6gzNJmUw39Gp-8wXvylxt4_1_P8LTUpqNAA130_provenance.